Skip to main content

Advertisement

Table 3 Immunohistochemistry (IHC) and fluorescence in-situ hybridization (FISH) results for HER2 protein expression and gene amplification respectively with amplification (in bold) observed in 3/16 (18.8%) mucinous borderline tumors of the ovary.

From: HER2 overexpression and amplification is present in a subset of ovarian mucinous carcinomas and can be targeted with trastuzumab therapy

ID IHC (HER2) HER2/CEP 17 Ratio IHC/FISH concordance
VB1 0 0.9  
VB2 0 0.8  
VB3 0 0.8  
VB4 1 1.2  
VB5 0 1.2  
VB6 0 1.0  
J1 3 3.2  
J2 0 0.8  
J3 0 1.2  
J4 0 1.1  
J5 0 1.1  
J6 0 1.2  
J7 0 2.4 Discordant
J8 2 3.1  
J9 0 1.3  
J10 0 1.3